• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服和直肠给药后氧烯洛尔的药代动力学——给药系统与给药途径的比较

The pharmacokinetics of oxprenolol following oral and rectal dosing--a comparison of delivery systems and routes of administration.

作者信息

Gregg M R, Jack D B, Smith S R, Kendall M J

出版信息

J Clin Pharm Ther. 1987 Apr;12(2):91-9. doi: 10.1111/j.1365-2710.1987.tb00513.x.

DOI:10.1111/j.1365-2710.1987.tb00513.x
PMID:3584272
Abstract

Plasma oxprenolol concentrations were measured in eight healthy volunteers who received equivalent oral doses of the drug in the form of an aqueous solution and a 10/170 oxprenolol Oros drug delivery system. Absorption from the lower gastrointestinal tract was assessed by measurement of plasma concentrations after rectal administration of the pre-equilibrated Oros systems. Because three of the first four volunteers suffered local irritation, however, the other four volunteers received Slow Trasicor 160 mg orally as a comparative preparation. The rate of in vivo absorption after oral administration of the Oros system closely mirrored its in vitro release rate. Drug availability from Oros was reduced, however, and was equivalent to 77% of that from the oral solution. Oxprenolol was well absorbed from the rectum while the system was present in this segment of the gut. The reduced systemic availability in three of the volunteers could be accounted for largely by drug loss when the system was expelled. Slow Trasicor produced higher peaks but lower 24 h plasma concentrations than the orally administered Oros system. As judged from the relative areas under the plasma concentration-time curve, however, the availability of the drug from the two dosage forms was comparable.

摘要

在八名健康志愿者中测量了血浆氧烯洛尔浓度,这些志愿者分别以水溶液和10/170氧烯洛尔渗透泵控释给药系统的形式接受了等效口服剂量的该药物。通过直肠给予预平衡的渗透泵控释系统后测量血浆浓度来评估下消化道的吸收情况。然而,由于前四名志愿者中有三名出现局部刺激,其他四名志愿者口服160 mg盐酸心得宁作为对照制剂。口服渗透泵控释系统后的体内吸收速率与其体外释放速率密切相关。然而,渗透泵控释系统的药物利用率降低,相当于口服溶液的77%。当渗透泵控释系统存在于肠道的这一部分时,氧烯洛尔从直肠吸收良好。三名志愿者全身利用率降低很大程度上可归因于系统排出时的药物损失。盐酸心得宁产生的峰浓度较高,但24小时血浆浓度低于口服渗透泵控释系统。然而,从血浆浓度-时间曲线下的相对面积判断,两种剂型的药物利用率相当。

相似文献

1
The pharmacokinetics of oxprenolol following oral and rectal dosing--a comparison of delivery systems and routes of administration.口服和直肠给药后氧烯洛尔的药代动力学——给药系统与给药途径的比较
J Clin Pharm Ther. 1987 Apr;12(2):91-9. doi: 10.1111/j.1365-2710.1987.tb00513.x.
2
A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.在健康志愿者中进行的氧烯洛尔聚合物基质剂型和渗透泵控释剂型的药效学及药代动力学行为的多剂量对比研究。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):177S-184S. doi: 10.1111/j.1365-2125.1985.tb02759.x.
3
Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.健康志愿者中氧烯洛尔聚合物基质剂型(Slow Trasicor)和渗透泵控释剂型的单剂量药代动力学和药效学比较。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):171S-175S. doi: 10.1111/j.1365-2125.1985.tb02758.x.
4
Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage form.口服氧烯洛尔渗透泵控释片剂型后年轻女性志愿者体内氧烯洛尔血药浓度的重现性。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):185S-190S. doi: 10.1111/j.1365-2125.1985.tb02760.x.
5
Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release.氧烯洛尔从渗透泵控释系统在健康志愿者体内吸收的药代动力学研究:体内与体外药物释放的比较
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):163S-169S. doi: 10.1111/j.1365-2125.1985.tb02757.x.
6
Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations.食物摄入对口服常规制剂和渗透泵控释制剂后血浆氧烯洛尔浓度的影响。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):191S-195S. doi: 10.1111/j.1365-2125.1985.tb02761.x.
7
Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing.与口服给药后相比,单次大剂量给药至结肠的两个节段后人体内氧烯洛尔的吸收情况。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):137S-142S. doi: 10.1111/j.1365-2125.1985.tb02754.x.
8
Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.单剂量和多剂量缓释Oros氧烯洛尔给药系统在年轻血压正常者和老年高血压患者中药代动力学特征的比较。
Br J Clin Pharmacol. 1986 Apr;21(4):371-6. doi: 10.1111/j.1365-2125.1986.tb05209.x.
9
Pharmacokinetics of oxprenolol in normal subjects.氧烯洛尔在正常受试者体内的药代动力学。
Clin Pharmacol Ther. 1976 Oct;20(4):401-12. doi: 10.1002/cpt1976204401.
10
Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites.犬体内氧烯洛尔和美托洛尔渗透泵系统的评价:体内外药物释放及十二指肠和结肠输注部位药物吸收的比较
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):91S-95S. doi: 10.1111/j.1365-2125.1985.tb02748.x.

引用本文的文献

1
Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.新型药物递送系统。其对临床药代动力学研究影响的概述。
Clin Pharmacokinet. 1991 Jan;20(1):1-14. doi: 10.2165/00003088-199120010-00001.
2
Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.直肠给药的药代动力学,第二部分。外周作用药物的临床应用及结论。
Clin Pharmacokinet. 1991 Aug;21(2):110-28. doi: 10.2165/00003088-199121020-00003.